Medical device maker BD (Becton Dickinson) has withdrawn from talks aimed at resolving a dispute over severance packages for ...

Crossmark Global Holdings Inc. boosted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 1.8% during ...

Becton, Dickinson plans to reduce debt and repurchase $1B in shares. Read why BDX stock is a solid Buy, enhancing financial ...

Axxcess Wealth Management LLC raised its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.0% in the ...

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00. The company’s shares opened today at $226.95. Wise covers ...

The global sales of central venous catheters (CVC) are estimated to be valued at USD 2,861.0 million in 2024 and are expected ...

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Hello and welcome to BD’s Fourth Quarter and Full Year Fiscal ...

--Down 6.25% year-to-date; on pace for worst year since 2020, when it fell 8% --Down 19.4% from its all-time closing high of $283.59 on July 27, 2023 --Down 1.57% from 52 weeks ago (Nov. 9, 2023), ...

BD's Q4 sales rose 6.9% to $5.44 billion, beating estimates. EPS of $3.81 also topped forecasts. FY25 guidance includes $21.9 ...